Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Lamisil At Terbinafine Hydrochloride 1 g/100g Cream — NDC 61047-139-02 (Billing 61047-0139-02)
by Voyant Beauty, Inc. · 1 TUBE in 1 CARTON / 12 g in 1 TUBE
This is a package of Lamisil At Terbinafine Hydrochloride 1 g/100g Cream from Voyant Beauty, Inc., marketed since Aug 2024 and currently FDA-listed.
NDC 61047-0139-02
🏷️ FDA NDC (as labeled)
61047-139-02
billing pads the product segment with a zero
This package
Contains12 g in 1 tube
Pack sizes2 compare ↓
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
61047-139-02
Product NDC
61047-139
11-digit billing NDC
61047013902
UNII
012C11ZU6G
Application #
NDA020980
SPL Set ID
1fd313ad-a3d9-6c86-e063-6394a90a7ae4
Established class (EPC)
Allylamine Antifungal
Chemical class
Allylamine
DEA schedule
Non-controlled
Marketing category
NDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2024-08-21
Route
TOPICAL
Dosage form
CREAM
Substance
TERBINAFINE HYDROCHLORIDE
Quick answers
- RxCUI (RxNorm): 992528
Why two NDCs?
The FDA registers this code as 61047-139-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 61047-0139-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Allylamine Antifungal class.
Pharmacologic class
Allylamine Antifungal
Drug family (ATC)
Other antifungals for topical use, Antifungals for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
📗 Our plain-language guide HelloPharmacist
- It depends on the form. The tablets treat fungal infections of the toenails or fingernails. Topical products like Lamisil AT treat athlete’s foot, jock itch and ringworm. Your doct...
- You take one tablet by mouth once a day, with or without food. Fingernails take a shorter course than toenails. Your nail can look better only after healthy nail grows out, which t...
- Liver failure has happened with terbinafine tablets, even in people with no liver problems. A blood test before and during treatment helps catch trouble early. Call your doctor rig...
- Headache, diarrhea, rash, upset stomach and itching are the common ones, and they are usually mild. Call your doctor for taste or smell changes, low mood, blistering or spreading r...
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
💬 Questions about Terbinafine hydrochloride?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
30 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 3, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 61047-0139-01 61047-139-01 Main listing | 1 TUBE in 1 CARTON / 30 g in 1 TUBE | 2024-08-21 | — | Active |
| 61047-0139-02 You're viewing this | 1 TUBE in 1 CARTON / 12 g in 1 TUBE | 2025-01-06 | — | Active |
Pack size FAQ
What quantity is in this package?
This package is listed by the FDA — 1 tube in 1 carton / 12 g in 1 tube.
What NDC number is used to bill for this package of Lamisil At Terbinafine Hydrochloride 1 g/100g Cream?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Good Neighbor Pharmacy 1 g/100g 24385-0524-03 | AmerisourceBergen | 1 tube | $0.231 | — | Availability likely | — |
| Terbinafine Hydrochloride 1 g/100g 70677-1003-01 | STRATEGIC | 1 tube | $0.309 | — | Availability likely | — |
| Terbinafine Hydrochloride 1 g/100g 51672-2080-01 | Sun | 1 tube | $0.398 | — | Availability likely | — |
| Terbinafine Hydrochloride 1 g/100g 70000-0338-01 | Cardinal | 1 tube | $0.398 | — | Availability likely | — |
| Walgreens Athletes Foot 1 g/100g 00363-2080-01 | Walgreen | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 00363-4502-02 | WALGREEN | 1 tube | — | — | FDA listed | — |
| Athletes Foot 1 g/100g 11822-0080-01 | Rite | 1 tube | — | — | FDA listed | — |
| Kroger Antifungal 1 g/100g 30142-0080-01 | Kroger | 1 tube | — | — | FDA listed | — |
| Athletes Foot 1 g/100g 37808-0080-01 | H | 1 tube | — | — | FDA listed | — |
| Antifungal 1 g/100g 41250-0080-02 | Meijer | 1 tube | — | — | FDA listed | — |
| equate Athletes Foot 1 g/100g 49035-0080-03 | Wal-Mart | 1 tube | — | — | FDA listed | — |
| Silka Antifungal 1 g/100g 50066-0080-02 | Genomma | 1 tube | — | — | FDA listed | — |
| Silka Jock Itch 1 g/100g 50066-0208-05 | Genomma | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 50090-1278-00 | A-S | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 50090-5810-00 | A-S | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 51672-2140-01 | Sun | 1 tube | — | — | FDA listed | — |
| Athletes Foot 1 g/100g 56062-0080-02 | Publix | 1 tube | — | — | FDA listed | — |
| CVS Pharmacy Athletes Foot 1 g/100g 59779-0080-01 | CVS | 1 tube | — | — | FDA listed | — |
| Cvs 1 g/100g 59779-0523-01 | CVS | 1 tube | — | — | FDA listed | — |
| Lamisil AT Cream 1 g/100g 61047-0120-01 | Voyant | 1 tube | — | — | Discontinued | — |
| Lamisil At Terbinafine Hydrochloride 1 g/100gthis 61047-0139-02 | Voyant | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 63187-0111-15 | Proficient | 1 tube | — | — | FDA listed | — |
| Good Neighbor Pharmacy 1 g/100g 68788-4044-01 | Preferred | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 68788-9814-01 | Preferred | 15 g | — | — | FDA listed | — |
| Curist Antifungal Relief 1 g/100g 72559-0035-58 | Little | 1 tube | — | — | FDA listed | — |
| Terbinafine Hydrochloride 1 g/100g 73469-7215-02 | Scholl's | 1 tube | — | — | FDA listed | — |
| PHARMBANNER TINEA VERSICOLOR Cream 1 g/100g 83818-0024-01 | Shenzhen | 60 g | — | — | FDA listed | — |
| Lamisil AT Cream 1 g/100g 84485-3607-01 | Karo | 1 tube | — | — | FDA listed | — |
| Lamisil AT Cream 1 g/100g 84485-3748-03 | Karo | 1 tube | — | — | FDA listed | — |
| Lamisil AT Cream 1 g/100g 84485-4030-01 | Karo | 1 tube | — | — | FDA listed | — |
| Athlete Foot Cream 1 g/100g 85398-0006-01 | Beautivity | 60 g | — | — | FDA listed | — |
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2024
On the market since
Aug 2024
📍
2026
Currently FDA-listed
2 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerVoyant Beauty, Inc.
Application holderKARO HEALTHCARE INC
FDA applicationNDA020980 (NDA)
Labeler code61047
First marketedAug 2024
Product typeHuman Otc Drug
Portfolio7 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Do Not Use
📄 When Using This Product
📄 Stop Use and Ask a Doctor If
📄 Keep Out of Reach of Children
📄 Questions or Comments
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
- cures most athlete's foot (tinea pedis) - cure most jock itch (tinea cruris) and ringworm (tinea corporis) - relieves itching, burning, cracking andf scaling which accompany this condition
⏱️ Dosage and Administration ▾
Directions - adults and children 12 years and over: - use the tip of the cap to break the seal and open the tube - wash the affected skin with soap and water and dry completely before applying - for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily. - between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor - on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor - for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor - wash hands after each use - children under 12 years: ask a doctor
⚠️ Warnings ▾
For external use only
📦 Storage and Handling ▾
Other Information - do no use if seal on tube is broken or is not visible - store at controlled room temperature 20-25C (68-77F)
🧪 Active Ingredient ▾
Terbinafine hydrochloride 1%
🧪 Inactive Ingredients ▾
benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearly alcohol
🎯 Purpose ▾
Antifungal
📄 Do Not Use ▾
- on nails or scalp - in or near the mouth or eyes - for vaginal yeast infections
📄 When Using This Product ▾
do not get into eyes. If eye contact occurs, rinse thoroughly with water
📄 Stop Use and Ask a Doctor If ▾
ask a doctor if too much irritation occurs or gets worse
📄 Keep Out of Reach of Children ▾
If swallowed, get medical help or contact a Poison Control Center right away.
📄 Questions or Comments ▾
call 1-888-544-1880
📄 Package Label / Principal Display Panel ▾
30g (1oz) Lamisil AT Cream Terbinafine Hydrochloride Cream 1% - Antifungal For Athlete's Foot Relieves Itching Clinically Proven to cure most athelete's foot between the toes Fill prescription strength NET WT 30 g (1 oz) new carton 30g new tube 30g Tube Carton
12g (0.42oz) LAMISIL AT CREAM TERBINAFINE HYDROCHLORIDE CREAM 1% - ANTIFUNGAL FOR JOCK ITCH CURES MOST JOCK ITCH FOR EFFECTIVE REFLIEF OF ITCHING AND BURNING NEW WT 12G (0.42OZ) TUBE 12g CARTON 12g
12g new graphics NOW AVAILABEL LAMISIL AT CREAM TERBINAFINE HYDROCHLORIDE CREAM 1% - ANTIFUNGAL ALL-IN-ONE Athlete's Foot - Jock Itch - Ringworm Clinically proven to cure most athlete's foot, jock itch, and ringworm Effective relief of itching, burning, cracking and scaling Full Prescription Strength Net wt 12g (0.42oz) Carton 12g new Tube 12g new
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Terbinafine hydrochloride — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 48%
Female · 52%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Voyant Beauty, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 tube (61047-0139-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Voyant Beauty, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.